Axonics 2501 Handbuch Seite 9

AXONICS SNM SYSTEM FOR URINARY CONTROL
Indications
Axonics SNM Therapy for urinary control is indicated for the treatment of urinary retention and the symptoms of
overactive bladder, including urinary urge incontinence and significant symptoms of urgency‐frequency alone or in
combination, in patients who have failed or could not tolerate more conservative treatments.
Precautions
Clinician Training
Implanting clinicians should be trained on the implantation and use of the Axonics SNM System.
•
Prescribing clinicians should be experienced in the diagnosis and treatment of lower urinary tract symptoms and
•
should be trained on the use of the Axonics SNM System.
Use in Specific Populations
The safety and effectiveness of this therapy has not been established for:
Pregnant women
•
Pediatric use (patients under the age of 16)
•
Patients with neurological disease origins, such as multiple sclerosis or diabetes
•
Bilateral stimulation
•
Contraindications
The Axonics SNM System is contraindicated for patients who are unable to operate the Axonics SNM System.
5